In addition, we found that the expression of both WDR26 and NCOA5 increased over the progression of breast cancer (Supplementary Fig. 4a, b) and were enriched in highly aggressive and poorly differentiated grade three tumours compared with grade 1 and 2 cases (Supplementary Fig. 4c, d). This evidence concerns the gene NCOA5 and breast carcinoma.